Pharma FLDP Analyst Looking to Pivot into IB via MBA

Hey everyone,

I’m currently in a rotational finance program at an F100 pharma company. Graduated from a LOW semi-target and studied finance, ~3.7 GPA. 

The program has been a good first job out of undergrad with a brand name, but I’d like to be somewhere that pushes me harder and builds deal skills faster. The people on corpdev teams I’ve spoken with almost always come from IB/MBB/MBA backgrounds or have been with the company for years. 

The rotational programs do have a lot going for them. Assignments in certain areas provide real exposure to the pipeline and everything associated with drug commercialization. But rotation placement makes or breaks your experience, and a lot of assignments like SOX compliance or audit feel like dead ends. 

I’m seriously considering an MBA as a path into healthcare IB. I'm studying for the GMAT right now and plan to apply in 2-3 years. I know most of the core modeling and have a solid grasp of pharma-specific finance. I also regularly keep up with the markets and have had a strong interest in the pharma industry anyway so this feels like a good fit and natural progression. 


A few questions:

  1. Is the MBA associate pathway still relevant?
  2. Which programs should I look into for HC coverage groups?
  3. Does applying in 2-3 years make sense, or should I be thinking about the timeline differently?
  4. Is there anything else I should be doing in the meantime to strengthen my application or set myself up for later down the line?
     
0 Comments

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”